Arvinas, Inc. (ARVN)
13.32
+0.53
(+4.14%)
USD |
NASDAQ |
Dec 08, 16:00
13.31
-0.01
(-0.08%)
After-Hours: 20:00
Arvinas Research and Development Expense (Quarterly): 64.30M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pfizer Inc. | 2.492B |
| Assembly Biosciences, Inc. | 16.56M |
| Alnylam Pharmaceuticals, Inc. | 358.81M |
| Verastem, Inc. | 28.99M |
| Sarepta Therapeutics, Inc. | 218.89M |